SS

Shripal Singh Shishodia

Active Director Director DIN 08762321
DIN 08762321 First appointment Jun 2020 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Shripal Singh Shishodia

Data last updated:

Shripal Singh Shishodia is a Director at Lymph Technologies Private Limited (since 2020). The company operates in Information Technology.

DIN 08762321
Primary Designation Director
Industry Information Technology
First Appointment 14 Jun 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lymph Technologies Private Limited U72900UP2020PTC129515
Director14 Jun 20202020Active

Board colleagues of Shripal Singh Shishodia

NameDINCompanyDesignation
Rohit Singh Rana08762320Lymph Technologies Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Lymph Technologies Private Limited
Premium access

Shareholding and investment profile for Shripal Singh Shishodia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shripal Singh Shishodia

Shripal Singh Shishodia currently holds 1 directorship: Lymph Technologies Private Limited (Director, since 14 Jun 2020).

Shripal Singh Shishodia was first appointed on 14 Jun 2020 as Director at Lymph Technologies Private Limited.

The current boards of Shripal Singh Shishodia's companies include Rohit Singh Rana (Lymph Technologies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available